Therefore, although further validation is required, the upregulation of CD137 expression on NPC cells in the context of abundant CD137+ T cells observed in NPC may reflect an immune evasion strategy, wherein NPC-expressed CD137 competitively binds CD137L on APCs to limit costimulatory signaling to T cells. The gene discussed is TNFSF9; the disease is nasopharyngeal carcinoma.